Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Montagut

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 12, 2025
Definition of lines of treatment in metastatic colorectal cancer: a Delphi consensusPilar García-Alfonso, Julia Alcaide-Garcia, Enrique Aranda Aguilar, et al.
Molecular Cancer Therapeutics|April 3, 2016
Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR TherapiesDaniel Azuara, Cristina Santos, Adriana Lopez-Doriga, et al.
Molecular Cancer Therapeutics|September 6, 2019
HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric CancerAïda Sampera, Francisco Javier Sánchez-Martín, Oriol Arpí, et al.
Molecular Cell|July 15, 2019
IKKα Kinase Regulates the DNA Damage Response and Drives Chemo-resistance in CancerCarlota Colomer, Pol Margalef, Alberto Villanueva, et al.
Nature Medicine|January 25, 2012
Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancerClara Montagut, Alba Dalmases, Beatriz Bellosillo, et al.
Experimental and Molecular Pathology|September 27, 2015
Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanomaLinea Melchior, Morten Grauslund, Beatriz Bellosillo, et al.
Plos One|November 24, 2012
Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a TTD group cooperative studyEduardo Díaz-Rubio, Auxiliadora Gómez-España, Bartomeu Massutí, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 TrialJoana Vidal, David Casadevall, Beatriz Bellosillo, et al.
The Oncologist|September 12, 2014
Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter TrialCarlos Fernandez-Martos, Gina Brown, Rafael Estevan, et al.
British Journal of Cancer|December 10, 2025
ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumorsLaura Solé, Eric Canton, María Maqueda, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 12, 2025
Definition of lines of treatment in metastatic colorectal cancer: a Delphi consensusPilar García-Alfonso, Julia Alcaide-Garcia, Enrique Aranda Aguilar, et al.
Molecular Cancer Therapeutics|April 3, 2016
Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR TherapiesDaniel Azuara, Cristina Santos, Adriana Lopez-Doriga, et al.
Molecular Cancer Therapeutics|September 6, 2019
HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric CancerAïda Sampera, Francisco Javier Sánchez-Martín, Oriol Arpí, et al.
Molecular Cell|July 15, 2019
IKKα Kinase Regulates the DNA Damage Response and Drives Chemo-resistance in CancerCarlota Colomer, Pol Margalef, Alberto Villanueva, et al.
Nature Medicine|January 25, 2012
Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancerClara Montagut, Alba Dalmases, Beatriz Bellosillo, et al.
Experimental and Molecular Pathology|September 27, 2015
Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanomaLinea Melchior, Morten Grauslund, Beatriz Bellosillo, et al.
Plos One|November 24, 2012
Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a TTD group cooperative studyEduardo Díaz-Rubio, Auxiliadora Gómez-España, Bartomeu Massutí, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 TrialJoana Vidal, David Casadevall, Beatriz Bellosillo, et al.
The Oncologist|September 12, 2014
Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter TrialCarlos Fernandez-Martos, Gina Brown, Rafael Estevan, et al.
British Journal of Cancer|December 10, 2025
ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumorsLaura Solé, Eric Canton, María Maqueda, et al.
Pageof 8